×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| LINCOLN PHARMACEUTICALS LTD. | 1693.38 | 276.75 | 1540.67 | 13.82 | 1,127 | 13.0 |
| KMC SPECIALITY HOSPITALS (INDI | NA | NA | NA | NA | 1098 | 46.8 |
| FERMENTA BIOTECH LIMITED | NA | NA | NA | NA | 1043 | 9.93 |
Lincoln Pharmaceuticals ltd., with Security Code 531633, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 112.5 | 135.6 | 156.0 | 146.4 | 142.5 | 147.3 | 161.2 | 146.6 | 168.2 | 154.1 |
| Expenses | 95.9 | 114.9 | 124.8 | 116.8 | 124.1 | 124.6 | 132.8 | 122.9 | 141.4 | 130.3 |
| Operating Profit | 16.6 | 20.7 | 31.1 | 29.7 | 18.4 | 22.7 | 28.4 | 23.7 | 26.8 | 23.8 |
| OPM % | 14.76% | 15.28% | 19.97% | 20.25% | 12.9% | 15.43% | 17.6% | 16.15% | 15.92% | 15.45% |
| Other Income | 3.9 | 7.7 | 8.7 | 11.0 | 7.0 | 10.4 | 10.0 | 9.0 | -6.9 | 15.3 |
| Interest | 1.1 | 0.4 | 0.4 | 0.2 | 0.5 | 0.4 | 0.3 | 0.7 | 0.4 | 0.2 |
| Depreciation | 2.4 | 2.5 | 2.6 | 2.8 | 2.7 | 3.2 | 3.2 | 3.2 | 3.2 | 3.5 |
| Profit before tax | 17.0 | 25.4 | 36.9 | 37.7 | 22.2 | 29.5 | 34.8 | 28.7 | 16.3 | 35.4 |
| Tax % | -26% | -25.3% | -25% | -25.6% | -16.3% | -19.7% | 24.3% | -27.6% | -28.3% | 21.8% |
| Net Profit | 12.6 | 19.0 | 27.7 | 28.0 | 18.6 | 23.7 | 26.3 | 20.8 | 11.6 | 27.7 |
| EPS in Rs | 6.27 | 9.49 | 13.81 | 14 | 9.28 | 11.82 | 13.15 | 10.37 | 0 | 13.82 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 133.8 | 112.5 | 135.6 | 156.0 | 146.4 | 142.5 | 147.3 | 161.2 | 146.6 | 168.2 |
| Expenses | 107.0 | 95.8 | 114.9 | 124.8 | 116.8 | 124.1 | 124.6 | 132.8 | 122.9 | 141.4 |
| Operating Profit | 26.8 | 16.6 | 20.7 | 31.1 | 29.7 | 18.4 | 22.7 | 28.4 | 23.7 | 26.8 |
| OPM % | 20% | 14.8% | 15.28% | 19.97% | 20.25% | 12.9% | 15.43% | 17.6% | 16.15% | 15.92% |
| Other Income | 6.4 | 3.9 | 7.7 | 8.7 | 11.0 | 7.0 | 10.4 | 10.0 | 9.0 | -6.9 |
| Interest | 0.3 | 1.1 | 0.4 | 0.4 | 0.2 | 0.5 | 0.4 | 0.3 | 0.7 | 0.4 |
| Depreciation | 2.3 | 2.4 | 2.5 | 2.6 | 2.8 | 2.7 | 3.2 | 3.2 | 3.2 | 3.2 |
| Profit before tax | 30.5 | 17.0 | 25.4 | 36.9 | 37.7 | 22.2 | 29.5 | 34.8 | 28.7 | 16.3 |
| Tax % | -29.2% | -26% | -25.3% | -25% | -25.6% | -16.3% | 19.7% | -24.3% | 27.6% | -28.3% |
| Net Profit | 21.6 | 12.6 | 19.0 | 27.7 | 28.0 | 18.6 | 23.7 | 26.3 | 20.8 | 11.6 |
| EPS in Rs | 10.79 | 6.27 | 9.49 | 13.81 | 14 | 9.28 | 11.82 | 13.15 | 10.37 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 11% |
| 3 Years: | 6% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 28% |
| 3 Years: | 25% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 10% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 28% |
| 3 Years: | 25% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|